TransDigm Group INC - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by TransDigm Group Incorporated on August 28, 2014. The filing discloses the execution of a Third Amended and Restated Employment Agreement with W. Nicholas Howley, the Company's Chairman and Chief Executive Officer.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation terms.
Material Changes
The primary material change is the extension and modification of Mr. Howley's employment terms:
- Term Extension: The agreement term was extended from an expiration date of December 31, 2015, to July 31, 2019.
- Base Salary: Set at $1,040,000 annually, subject to review (increases permitted, decreases not).
- Annual Bonus: Target bonus set at 125% of base salary.
- Equity Grants: Annual option grants valued at $10,600,000 (Black-Scholes basis), increasing annually by 3.5%.
- Stock Ownership: Mr. Howley is required to hold stock or vested in-the-money options valued at least $10,000,000, with a minimum of $5,000,000 held in stock.
Outlook, Risks, and Contingencies
The agreement outlines significant severance contingencies triggered by termination without cause, death, disability, or "good reason" (including material diminution of duties, salary reduction, or relocation over 30 miles from Cleveland).
- Severance Payment: Upon qualifying termination, Mr. Howley is entitled to two times his annual salary plus two times the greater of the prior year's bonus or the target bonus for the termination year. Payments are made in substantially equal installments over 24 months.
- Executive Chairman Exception: If resignation for good reason is due to a title change to Executive Chairman, severance is reduced to one times salary and bonus.
- Option Vesting: Specific accelerated vesting schedules apply upon qualifying termination, ranging from 30% to 100% of remaining unvested options depending on the timing of termination relative to the grant date.
- Termination for Cause: Vested options expire 18 months following termination.
- Benefits: Includes COBRA coverage at pre-termination rates and post-retirement Medicare supplemental coverage.
Investor Verification Checklist
- Verify the full text of the Third Amended and Restated Employment Agreement filed as Exhibit 10.1.
- Confirm the specific definitions of "Good Reason," "Without Cause," and "Change in Control" within the agreement.
- Review the Company's stock option plan to understand the performance vesting criteria referenced for the new grants.
- Assess the impact of the $10.6 million annual option grant value on future dilution and compensation expense.